Full Text View
Tabular View
No Study Results Posted
Related Studies
Ivermectin Versus Albendazole for Chronic Strongyloidiasis
This study is enrolling participants by invitation only.
Study NCT00765024   Information provided by Mahidol University
First Received: September 30, 2008   Last Updated: September 17, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Strongyloidiasis
Additional conditions recognized in this trial
Strongyloidiasis
More general conditions related to this trial
Helminthiasis
Nematode Infections
Parasitic Diseases
Rhabditida Infections
Secernentea Infections
Interventions listed in this trial
albendazole
Ivermectin
More general drug interventions related to this trial
Anthelmintics
Anti-Infective Agents
Anticestodal Agents
Antimitotic Agents
Antineoplastic Agents
Antiparasitic Agents
Antiplatyhelmintic Agents
Antiprotozoal Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Mahidol University
Atlantic Laboratory Ltd


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services